[
    [
        {
            "time": "",
            "original_text": "康泰生物：新冠灭活疫苗III期临床试验目前在马来西亚、菲律宾等国家按计划有序推进",
            "features": {
                "keywords": [
                    "康泰生物",
                    "新冠灭活疫苗",
                    "III期临床试验",
                    "马来西亚",
                    "菲律宾"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "康泰生物：新冠灭活疫苗III期临床试验目前在马来西亚、菲律宾等国家按计划有序推进",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "双抗药物爆发，40多家药企布局",
            "features": {
                "keywords": [
                    "双抗药物",
                    "药企",
                    "布局"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "双抗药物爆发，40多家药企布局",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]